# Lineage Cell Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 10-K/A
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 16:15 ET
- Period: 2022-12-31
- Accession: 0001493152-23-013813
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315223013813/form10-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315223013813/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315223013813/form10-ka.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-013813. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
